On November 29, the Leasing Industry Working Committee of the China Association of Enterprises with Foreign Investment released the "2023 China Financial Leasing List". After the unanimous approval of industry experts and scholars, State-owned Leasing was awarded the "2023 China Financial Leasing Company of the Year" for its outstanding performance in serving the real economy and stable operation in the past year.
Founded in 1988, the Leasing Industry Working Committee of the China Association of Enterprises with Foreign Investment is the first national financial leasing association in China. Since its inception in 2007, the "China Financial Leasing List" has been selected for 16 consecutive years, and has been actively participated and widely recognized by enterprises in the industry. The purpose of the selection is to encourage financial leasing enterprises to improve their professional capabilities, establish a good image of industry development, guide financial leasing enterprises to implement national industrial policies, and better serve the development of the real economy.
As a subsidiary of Sinopharm Group, Sinopharm Leasing has always adhered to its original intention, rooted in the pharmaceutical and health industry, and made every effort to support the real economy. This is the fifth consecutive year that it has won the title of "China Financial Leasing Company of the Year", which is the industry's recognition of the work achievements of State-controlled Leasing in actively implementing the spirit of the Party Congress, implementing the national development strategy and helping the development of the real economy in the past year, and it is also a full affirmation of the company's sustainable and healthy development and outstanding achievements.
In the future, SOIC Leasing will give better play to the resource advantages of central enterprises, focus on medical and health care and related national strategic industries, take the dual-drive strategy of "industrial finance + technology operation" as the direction, practice the mission of "empowering the medical system and promoting industrial development with innovative services", go deep into the industry, and continue to provide high-quality integrated services for China's medical and health industryAnd actively fulfill social responsibilities, demonstrate the responsibility of the enterprise era, and make positive contributions to boosting the development of the real economy and promoting the national strategy of "Healthy China".